Silver Spring, Maryland–(ENEWSPF)–December 17, 2014. The U.S. Food and Drug Administration today approved Xtoro (finafloxacin otic suspension), a new drug used to treat acute otitis externa, commonly known as swimmer’s ear.
FDA Approves Xtoro to Treat Swimmer’s Ear
More in Health and Fitness:
